Encoded Therapeutics is creating one-time, disease-modifying gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. The Encoded approach offers potentially unprecedented gene specificity and cell selectivity to unlock novel opportunities by targeting a range of disease mechanisms. Encoded’s technology is compatible with any delivery system to control where and when therapeutic transgenes are expressed, thereby shaping the functionality of target cells and holding broader therapeutic potential beyond CNS disorders. For more information, please visit www.encoded.com, and follow us on LinkedIn, Twitter @EncodedTx and YouTube.
Social media guidelines: https://encoded.com/social-media-community-guidelines/
Industry
Biotechnology Research, Research, general, Research and testing, IT, Internet, R&D
HQ Location
341 Oyster Point Blvd
South San Francisco, California 94080, US
Keywords
biotechnologytherapeuticshealthcaregene therapy